vs
Compass, Inc.（COMP）与Solventum（SOLV）财务数据对比。点击上方公司名可切换其他公司
Solventum的季度营收约是Compass, Inc.的1.2倍（$2.0B vs $1.7B），Solventum净利率更高（3.2% vs -2.5%，领先5.7%），Compass, Inc.同比增速更快（23.1% vs -3.7%），Compass, Inc.自由现金流更多（$42.2M vs $32.0M），过去两年Compass, Inc.的营收复合增速更高（27.0% vs -0.4%）
Compass, Inc.是美国主营住宅房产经纪业务的企业，其平台旗下有约3.3万名经纪人，大多为独立合同工，运营Compass、21世纪不动产、科威国际不动产、苏富比国际地产、佳士得国际地产等多个知名房产经纪品牌。
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
COMP vs SOLV — 直观对比
营收规模更大
SOLV
是对方的1.2倍
$1.7B
营收增速更快
COMP
高出26.8%
-3.7%
净利率更高
SOLV
高出5.7%
-2.5%
自由现金流更多
COMP
多$10.2M
$32.0M
两年增速更快
COMP
近两年复合增速
-0.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $2.0B |
| 净利润 | $-42.6M | $63.0M |
| 毛利率 | — | 51.4% |
| 营业利润率 | -2.5% | 6.3% |
| 净利率 | -2.5% | 3.2% |
| 营收同比 | 23.1% | -3.7% |
| 净利润同比 | -5.2% | 103.2% |
| 每股收益（稀释后） | $-0.07 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COMPSOLV
| Q4 25 | $1.7B | $2.0B | ||
| Q3 25 | $1.8B | $2.1B | ||
| Q2 25 | $2.1B | $2.2B | ||
| Q1 25 | $1.4B | $2.1B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.5B | $2.1B | ||
| Q2 24 | $1.7B | $2.1B | ||
| Q1 24 | $1.1B | $2.0B |
净利润COMPSOLV
| Q4 25 | $-42.6M | $63.0M | ||
| Q3 25 | $-4.6M | $1.3B | ||
| Q2 25 | $39.4M | $90.0M | ||
| Q1 25 | $-50.7M | $137.0M | ||
| Q4 24 | $-40.5M | $31.0M | ||
| Q3 24 | $-1.7M | $122.0M | ||
| Q2 24 | $20.7M | $89.0M | ||
| Q1 24 | $-132.9M | $237.0M |
毛利率COMPSOLV
| Q4 25 | — | 51.4% | ||
| Q3 25 | — | 54.2% | ||
| Q2 25 | — | 54.4% | ||
| Q1 25 | — | 53.8% | ||
| Q4 24 | — | 53.9% | ||
| Q3 24 | — | 56.0% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 58.1% |
营业利润率COMPSOLV
| Q4 25 | -2.5% | 6.3% | ||
| Q3 25 | -0.4% | 80.6% | ||
| Q2 25 | 1.9% | 9.9% | ||
| Q1 25 | -4.0% | 7.3% | ||
| Q4 24 | -2.9% | 6.6% | ||
| Q3 24 | -0.2% | 13.2% | ||
| Q2 24 | 1.3% | 11.7% | ||
| Q1 24 | -12.5% | 18.9% |
净利率COMPSOLV
| Q4 25 | -2.5% | 3.2% | ||
| Q3 25 | -0.2% | 60.4% | ||
| Q2 25 | 1.9% | 4.2% | ||
| Q1 25 | -3.7% | 6.6% | ||
| Q4 24 | -2.9% | 1.5% | ||
| Q3 24 | -0.1% | 5.9% | ||
| Q2 24 | 1.2% | 4.3% | ||
| Q1 24 | -12.6% | 11.8% |
每股收益（稀释后）COMPSOLV
| Q4 25 | $-0.07 | $0.37 | ||
| Q3 25 | $-0.01 | $7.22 | ||
| Q2 25 | $0.07 | $0.51 | ||
| Q1 25 | $-0.09 | $0.78 | ||
| Q4 24 | $-0.08 | $0.18 | ||
| Q3 24 | $0.00 | $0.70 | ||
| Q2 24 | $0.04 | $0.51 | ||
| Q1 24 | $-0.27 | $1.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $199.0M | $878.0M |
| 总债务越低越好 | — | $5.0B |
| 股东权益账面价值 | $782.0M | $5.0B |
| 总资产 | $1.5B | $14.3B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资COMPSOLV
| Q4 25 | $199.0M | $878.0M | ||
| Q3 25 | $170.3M | $1.6B | ||
| Q2 25 | $177.3M | $492.0M | ||
| Q1 25 | $127.0M | $534.0M | ||
| Q4 24 | $223.8M | $762.0M | ||
| Q3 24 | $211.2M | $772.0M | ||
| Q2 24 | $185.8M | $897.0M | ||
| Q1 24 | $165.9M | $996.0M |
总债务COMPSOLV
| Q4 25 | — | $5.0B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | — | $7.8B | ||
| Q1 25 | — | $7.9B | ||
| Q4 24 | — | $8.0B | ||
| Q3 24 | — | $8.1B | ||
| Q2 24 | — | $8.3B | ||
| Q1 24 | — | $8.3B |
股东权益COMPSOLV
| Q4 25 | $782.0M | $5.0B | ||
| Q3 25 | $773.3M | $5.0B | ||
| Q2 25 | $719.9M | $3.6B | ||
| Q1 25 | $635.0M | $3.3B | ||
| Q4 24 | $409.4M | $3.0B | ||
| Q3 24 | $428.0M | $3.2B | ||
| Q2 24 | $398.4M | $2.9B | ||
| Q1 24 | $330.3M | $3.9B |
总资产COMPSOLV
| Q4 25 | $1.5B | $14.3B | ||
| Q3 25 | $1.6B | $14.0B | ||
| Q2 25 | $1.6B | $15.1B | ||
| Q1 25 | $1.5B | $14.5B | ||
| Q4 24 | $1.2B | $14.5B | ||
| Q3 24 | $1.2B | $14.7B | ||
| Q2 24 | $1.2B | $14.6B | ||
| Q1 24 | $1.1B | $14.7B |
负债/权益比COMPSOLV
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 2.14× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | 2.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.3M | $95.0M |
| 自由现金流经营现金流 - 资本支出 | $42.2M | $32.0M |
| 自由现金流率自由现金流/营收 | 2.5% | 1.6% |
| 资本支出强度资本支出/营收 | 0.2% | 3.2% |
| 现金转化率经营现金流/净利润 | — | 1.51× |
| 过去12个月自由现金流最近4个季度 | $203.3M | $-10.0M |
8季度趋势，按日历期对齐
经营现金流COMPSOLV
| Q4 25 | $45.3M | $95.0M | ||
| Q3 25 | $75.5M | $76.0M | ||
| Q2 25 | $72.8M | $169.0M | ||
| Q1 25 | $23.1M | $29.0M | ||
| Q4 24 | $30.5M | $219.0M | ||
| Q3 24 | $37.4M | $169.0M | ||
| Q2 24 | $45.0M | $355.0M | ||
| Q1 24 | $8.6M | $442.0M |
自由现金流COMPSOLV
| Q4 25 | $42.2M | $32.0M | ||
| Q3 25 | $73.6M | $-21.0M | ||
| Q2 25 | $68.0M | $59.0M | ||
| Q1 25 | $19.5M | $-80.0M | ||
| Q4 24 | $26.7M | $92.0M | ||
| Q3 24 | $32.8M | $76.0M | ||
| Q2 24 | $40.4M | $297.0M | ||
| Q1 24 | $5.9M | $340.0M |
自由现金流率COMPSOLV
| Q4 25 | 2.5% | 1.6% | ||
| Q3 25 | 4.0% | -1.0% | ||
| Q2 25 | 3.3% | 2.7% | ||
| Q1 25 | 1.4% | -3.9% | ||
| Q4 24 | 1.9% | 4.4% | ||
| Q3 24 | 2.2% | 3.7% | ||
| Q2 24 | 2.4% | 14.3% | ||
| Q1 24 | 0.6% | 16.9% |
资本支出强度COMPSOLV
| Q4 25 | 0.2% | 3.2% | ||
| Q3 25 | 0.1% | 4.6% | ||
| Q2 25 | 0.2% | 5.1% | ||
| Q1 25 | 0.3% | 5.3% | ||
| Q4 24 | 0.3% | 6.1% | ||
| Q3 24 | 0.3% | 4.5% | ||
| Q2 24 | 0.3% | 2.8% | ||
| Q1 24 | 0.3% | 5.1% |
现金转化率COMPSOLV
| Q4 25 | — | 1.51× | ||
| Q3 25 | — | 0.06× | ||
| Q2 25 | 1.85× | 1.88× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 7.06× | ||
| Q3 24 | — | 1.39× | ||
| Q2 24 | 2.17× | 3.99× | ||
| Q1 24 | — | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COMP
暂无分部数据
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
